Nina Kataria
Personalreferent bei NIOX GROUP PLC
Ursprung des Netzwerks ersten Grades von Nina Kataria
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Medical/Nursing Services | 28 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Nina Kataria
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Circassia Ltd.
 Circassia Ltd. Pharmaceuticals: OtherHealth Technology Circassia Ltd. develops medicines for allergic and auto-immune diseases. The company was founded by Anthony Barrington Kay and Mark Larché on December 29, 1998 and is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Other | Director/Board Member Director/Board Member Director/Board Member Director of Finance/CFO Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Zeneus Pharma Ltd.
 Zeneus Pharma Ltd. Medical DistributorsDistribution Services Zeneus Pharma Ltd. provides pharmaceutical products. It offers license to late-stage development, pre and post-approval, and marketing services across Europe for specialty hospital medicines. The company was founded in 2004 by Bryan Morton and is headquartered in Oxford, UK. | Medical Distributors | Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
| AEROCRINE AB | Electronic Equipment/Instruments | Chairman Director/Board Member Director/Board Member Consultant / Advisor | |
Institute of Chartered Accountants in England & Wales
 Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services The Institute of Chartered Accountants in England & Wales ensures that its members, students, and affiliates maintain the highest standards of professional competency and conduct to protect the public interest. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. With over 150,000 members, the institute provides technical information, helplines, and communities to its members. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Powderject Pharmaceuticals Plc
 Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Medical Specialties | Director of Finance/CFO Comptroller/Controller/Auditor Corporate Officer/Principal Director/Board Member | |
| University of Cambridge | College/University | Graduate Degree Doctorate Degree Graduate Degree Graduate Degree | |
Circassia Pharma Ltd.
 Circassia Pharma Ltd. Medical/Nursing ServicesHealth Services Circassia Pharma Ltd. is a biopharmaceutical company, which engages as a subsidiary of Circassia Pharmaceuticals plc. It focuses on the research and development of respiratory disease and allergy products. The company was founded on October 26, 2007 and is headquartered in Oxford, the United Kingdom. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member | |
Adiga Life Sciences, Inc.
 Adiga Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Adiga Life Sciences, Inc. operates as a healthcare company that conducts medical researches. It develops technologies to control immune function in allergic and auto immune diseases. The company was founded on November 25, 2008 and is headquartered in Hamilton, Canada. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Medical Specialties | Corporate Officer/Principal Chief Executive Officer | |
| PROCTER & GAMBLE COMPANY | Household/Personal Care | Corporate Officer/Principal Corporate Officer/Principal | |
IWH UK Holdco Ltd.
 IWH UK Holdco Ltd. Miscellaneous Commercial ServicesCommercial Services IWH UK Holdco Ltd. is a private company that provides business services. The company is based in London, UK. The British company was founded in 2017. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| NEOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| 3G Advisors LLC | Corporate Officer/Principal Corporate Officer/Principal | ||
Bioquell UK Ltd.
 Bioquell UK Ltd. Industrial MachineryProducer Manufacturing Part of Ecolab, Inc., Bioquell UK Ltd. is a company that specializes in decontamination and infection control solutions. The company is based in Andover, UK. The British company offers a range of products, including the Bioquell Qube, a modular aseptic workstation for rapid decontamination of samples and process materials. Bioquell's expertise lies in three key technologies: hydrogen peroxide vapor, oxygen peroxide technology, and advanced airborne gas and particulate filtering. | Industrial Machinery | Director/Board Member Director/Board Member | |
| BIOQUELL PLC | Medical Specialties | Chairman Director of Finance/CFO | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| CLINIGEN GROUP PLC | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Association of Chartered Certified Accountants
 Association of Chartered Certified Accountants Miscellaneous Commercial ServicesCommercial Services The Association of Chartered Certified Accountants (ACCA) is a professional body for accountants. The non-profit company is based in Glasgow, UK, and has subsidiaries in Mauritius, United Kingdom, and Hong Kong. The British company offers a program called ALP-C, which approves learning materials from high-quality content providers to support studying towards ACCA's qualification. The role of the CFO is evolving beyond finance to include reporting on value-centric aspects of their operations, as companies move towards sustainable practices. The CEO of the company is Helen Joanna Brand. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| BTG | Pharmaceuticals: Major | Chairman General Counsel | |
Brenn Distribution, Inc.
 Brenn Distribution, Inc. Pharmaceuticals: MajorHealth Technology Brenn Distribution, Inc. develops and distributes generic medicines. The company was founded on June 17, 1986 and is headquartered in Huntsville, AL. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| RECORDATI | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
IWH UK Finco Ltd.
 IWH UK Finco Ltd. Financial ConglomeratesFinance IWH UK Finco Ltd. functions as an investment holding private company. The company is based in London, UK. and has subsidiaries in United Kingdom. | Financial Conglomerates | Director/Board Member Director/Board Member | |
IWH UK Midco Ltd.
 IWH UK Midco Ltd. Financial ConglomeratesFinance IWH UK Midco Ltd. operates as an investment holding firm. The company was founded on September 4, 2017 and is headquartered in London, the United Kingdom. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Helsinn Holding SA
 Helsinn Holding SA Hospital/Nursing ManagementHealth Services Helsinn Holding SA is a holding Swiss company that provides cancer services through its subsidiaries. The private company is based in Lugano, Switzerland and has subsidiaries in Switzerland and Ireland. The company was founded in 1976 by Gabriele Edoardo Braglia. Riccardo Braglia has been the CEO of the company since 2002. | Hospital/Nursing Management | Director/Board Member | |
Micromega Ltd.
 Micromega Ltd. Miscellaneous Commercial ServicesCommercial Services Micromega Ltd. provides business support services. The private company is based in London, UK. The British company was founded by Francesco Granata. | Miscellaneous Commercial Services | Founder | |
FSI SGR SpA
 FSI SGR SpA Investment ManagersFinance FSI SGR SpA (FSI) also known as Fondo Strategico Italiano, is an independent private equity firm. The firm was founded in 2016 and is headquartered in Milan, Italy. | Investment Managers | Private Equity Investor | |
Helsinn Healthcare SA
 Helsinn Healthcare SA Pharmaceuticals: MajorHealth Technology Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Helsinn Healthcare SA /Venture/
 Helsinn Healthcare SA /Venture/ Investment ManagersFinance 3B FUTURE HEALTH VENTURES SARL (3B Future Health Ventures) is a venture capital subsidiary of Helsinn Healthcare SA founded in 2016. The firm is headquartered in Monaco, Luxembourg. | Investment Managers | Private Equity Investor | |
Diadem SpA
 Diadem SpA Miscellaneous Commercial ServicesCommercial Services Diadem Srl predicts, monitors, diagnosis and drug development for Alzheimer?s disease. focuses on specific research on early peripheral markers of Alzheimer's disease into technology. The company was founded by Maurizio Memo and Daniela Uberti in June 2012 and is headquartered in Brescia, Italy. | Miscellaneous Commercial Services | Director/Board Member | |
Akamis Bio Ltd.
 Akamis Bio Ltd. BiotechnologyHealth Technology Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member | |
UTILITY therapeutics Ltd.
 UTILITY therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Utility Therapeutics Ltd. is a British company that has exclusive US commercial rights to two European-approved antibiotics, mecillinam and an oral prodrug of mecillinam, for the treatment of urinary tract infections (UTI). The private company is based in Altrincham, UK and was founded in 2018 by Rasmus Toft-Kehler, Morten Otto Alexander Sommer, Peter Aksel Villadsen. Mecillinam is being developed as a first-line therapy for complicated UTI in the hospital setting, while the oral prodrug is being developed for uncomplicated UTI. The company has received the FDA's Qualified Infectious Disease Product (QIDP) designation for the treatment of UTI. Utility Therapeutics is committed to developing antibiotics that meet urgent treatment needs for multi-drug resistant infections. | Pharmaceuticals: Generic | Director/Board Member | |
Sensyne Health Holdings Ltd.
 Sensyne Health Holdings Ltd. Electronic Production EquipmentElectronic Technology Sensyne Health Holdings Ltd. provides wireless charging technology. It focuses on developing wireless energy devices and wireless sensor networks. The company was founded by Elspeth Drayson, Paul R. Drayson and Manuel Pinuela in April 2014 and is headquartered in London, the United Kingodm. | Electronic Production Equipment | Director/Board Member | |
Kyowa Kirin International Plc
 Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| Pharmacia & Upjohn SpA | Corporate Officer/Principal | ||
| SENSYNE HEALTH PLC | Miscellaneous Commercial Services | Chairman | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Warburg Pincus International LLC | Investment Managers | Private Equity Investor | |
Prismic Pharmaceuticals, Inc.
 Prismic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prismic Pharmaceuticals, Inc. engages in the research and development of prescription drugs for kidney disease, mental health, and chronic pain. It also offers medical foods for patients with chronic kidney disease, and depression and bipolar disorder. The company was founded by Zachary Dutton, Danilo Casadei Massari, and Peter J. Moriarty in 2011 and is headquartered in Worcester, MA. | Pharmaceuticals: Major | Director/Board Member | |
| University of Pavia | College/University | Doctorate Degree | |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Corporate Officer/Principal | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Quanta Dialysis Technologies Ltd.
 Quanta Dialysis Technologies Ltd. Medical SpecialtiesHealth Technology Quanta Dialysis Technologies Ltd. develops haemodialysis systems. The firm's SC+ is a performance, portable, compact haemodialysis system providing clinical efficacy utilising flow rates typically used on traditional machines. It offers SelfCare+, a haemodialysis machine for dialysis patients to control their disease and determine the treatment regime and care. The company was founded by Clive Henrey Buckberry, John Eric Milad and Martin Johnson in 2008 and is headquartered in Alcester, the United Kingdom. | Medical Specialties | Director/Board Member | |
Cell Therapy Ltd.
 Cell Therapy Ltd. BiotechnologyHealth Technology Cell Therapy Ltd. produces regenerative medicines using adult stem cells to treat heart failure. Its product HeartCel, a stem cell therapy that offers improved outcomes for heart failure patients by reducing the size of heart scar, improving heart function, quality of life and reducing mortality. The firm develops therapies based on the adult mesenchymal stromal cells technology platform. The firm’s regenerative therapies will focus on curing the cause of the disease, rather than only treating the symptoms. The company was founded in 2009 by Martin John Evans and Ajan Trevor Reginald and is headquartered in Cardiff, the United Kingdom. | Biotechnology | Director/Board Member |
Statistik
International
| Vereinigtes Königreich | 25 |
| Vereinigte Staaten | 14 |
| Italien | 6 |
| Kanada | 4 |
| Schweiz | 3 |
Sektoral
| Health Technology | 25 |
| Commercial Services | 9 |
| Finance | 7 |
| Electronic Technology | 3 |
| Consumer Services | 3 |
Operativ
| Director/Board Member | 185 |
| Corporate Officer/Principal | 86 |
| Independent Dir/Board Member | 58 |
| Chairman | 49 |
| Chief Executive Officer | 23 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Garry Watts | 31 |
| Ian Johnson | 29 |
| Cathrin Petty | 29 |
| Marvin Samson | 28 |
| Paul Edick | 27 |
| Francesco Granata | 24 |
| Timothy Corn | 20 |
| Lota Zoth | 20 |
| Jean-Jacques Garaud | 17 |
| Steven Harris | 16 |
| Hans Henrik Jacobson | 15 |
| Sharon Curran | 14 |
| Roderick Hafner | 12 |
| Michael Roller | 12 |
| Joanna Le Couilliard | 12 |
- Börse
- Insiders
- Nina Kataria
- Unternehmensverbindungen
